100mg Label (Metoprolol 100mg 30s)
Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 68001-503
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68001-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
200mg Label (Metoprolol 200mg 30s)
This is a description of a medication in tablet form called Metoprolol Succinate Extended-Release Tablets. It contains 190 mg of metoprolol succinate, USP, which is equivalent to 200 mg of metoprolol tartrate, USP. The medication is manufactured by Alkem Laboratories Ltd. in India and distributed by BluePoint Laboratories. The dosage information is available in the package insert, and caution is advised as with all medications to be kept out of the reach of children. The medication should be stored at room temperature between 15°C-30°C.*
25 mg Label (Metoprolol 25mg 30s)
Each film-coated tablet contains 23.75 mg metoprolol succinate, USP equivalent to 25 mg of metoprolol. The tablets are extended-release and should be kept out of the reach of children. They should be stored at room temperature and dispensed according to the USP guidelines. This product is manufactured by Alkem Laboratories Ltd in India. This label provides important dosage and warning information for Metoprolol Succinate ER Tablets.*
50mg Label (Metoprolol 50mg 30s)
This is a medication label for Metoprolol Succinate ER tablets, with a prescribed dosage of 50mg. The medication should be stored at 25°C and protected from light. The label includes a warning about the medication's potential side effects. The tablets were manufactured by UCB Pharma for Bausch Health Companies and the package contains 100 tablets.*
Metoprolol-structure (Metoprolol Structure)
Metoprolol-table1 (Metoprolol Table1)
This text contains the results for subgroups in MERIT-HF trial, a clinical study evaluating the effectiveness of metoprolol succinate extended-release tablets on heart failure. The data shows the relative risk and 95% confidence interval for total mortality, all-cause hospitalization, and hospitalization for heart failure based on different factors such as age, gender, race, previous medical conditions, and heart rate. The information is presented in a table format with some abbreviations defined.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
